Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

Genworth Financial, Inc. (GNW)

Life Insurance

https://www.genworth.com

Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, U.S. Life Insurance, and Runoff. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. most of the revenue is generated by the company's U.S. life insurance segment that offers long-term care insurance, fixed annuity, and traditional life insurance products. The company earns most of its revenue in the United States.

6620 WEST BROAD STREET
RICHMOND, VA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/25/2004

Market Cap

2,896,761,150

Shares Outstanding

451,010,000

Weighted SO

451,004,727

Total Employees

N/A

Upcoming Earnings

11/06/2024

Similar Tickers

AEL --.--%

MET-PA --.--%

NWLI --.--%

MDWT --.--%

PUK --.--%

PRI --.--%

CNO --.--%

AFL --.--%

FG --.--%

Beta

0.9240

Last Div

0.0000

Range

5.33-6.94

Chg

0.0650

Avg Vol

2963593

Mkt Cap

2896761150

Exch

NYSE

Country

US

Phone

804 281 6000

DCF Diff

144.1170

DCF

149.6070

Div Yield

0.0000

P/S

0.4171

EV Multiple

-26.6185

P/FV

0.3459

Div Yield %

0.0000

P/E

91.4394

PEG

-1.0537

Payout

1.3750

Current Ratio

-0.2189

Quick Ratio

-0.2189

Cash Ratio

-0.1132

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.9715

Op Margin

0.0674

Pretax Margin

0.0363

Net Margin

0.0046

Eff Tax Rate

0.3651

ROA

0.0005

ROE

0.0040

ROCE

0.0054

NI/EBT

0.1270

EBT/EBIT

0.5385

EBIT/Rev

0.0674

Debt Ratio

0.0224

D/E

0.1849

LT Debt/Cap

0.1560

Total Debt/Cap

0.1560

Int Coverage

1.9102

CF/Debt

0.1419

Equity Multi

8.2551

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.1447

Asset Turnover

0.0995

OCF/Share

0.5087

FCF/Share

0.8295

Cash/Share

7.3006

OCF/Sales

0.0320

FCF/OCF

1.6306

CF Coverage

0.1419

ST Coverage

0.0000

CapEx Coverage

1.5857

Div&CapEx Cov

1.2065

P/BV

0.3459

P/B

0.3459

P/S

0.4171

P/E

91.4394

P/FCF

8.0021

P/OCF

13.1805

P/CF

13.1805

PEG

-1.0537

P/S

0.4171

EV Multiple

-26.6185

P/FV

0.3459

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 08, 21:53 Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs GlobeNewswire Inc. Feb 15, 14:27 GRABAR LAW OFFICE IS INVESTIGATING CLAIMS ON BEHALF OF LONG-TERM SHAREHOLDERS OF ORIGIN MATERIALS, INC. (NASDAQ: ORGN); OLAPLEX HOLDINGS, INC. (NASDAQ: OLPX); TELEPHONE AND DATA SYSTEMS, INC. (NYSE: TDS); AND METHODE ELECTRONICS, INC. (NYSE: MEI) GlobeNewswire Inc. Feb 14, 23:31 Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision GlobeNewswire Inc. Jan 24, 22:34 Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure GlobeNewswire Inc. Jan 24, 00:53 Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference GlobeNewswire Inc. Oct 19, 02:46 Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days GlobeNewswire Inc. Oct 14, 22:43 Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections The Motley Fool Aug 01, 22:45 Genworth Financial (GNW) Q2 2024 Earnings Call Transcript GlobeNewswire Inc. Jul 14, 05:01 Global Long-Term Care Insurance Market Size To Worth USD 89.69 Billion by 2033 | CAGR of 14.01% - GlobeNewswire GlobeNewswire Inc. Dec 06, 17:00 Nogin Initiates Strategic Financial Restructuring; Operations to Continue Uninterrupted GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing GlobeNewswire Inc. Nov 22, 17:02 Nogin Announces Compliance with Nasdaq Listing Rule Regarding Form 10-Q Filing after Receiving Nasdaq Notice Regarding Late Form 10-Q Filing

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.10 10/08/2008 09/08/2008 10/10/2008 10/27/2008
0.10 07/09/2008 05/13/2008 07/11/2008 07/28/2008
0.10 04/09/2008 03/19/2008 04/11/2008 04/28/2008
0.10 01/09/2008 11/30/2007 01/11/2008 01/28/2008
0.10 10/10/2007 09/21/2007 10/12/2007 10/29/2007
0.09 07/10/2007 05/15/2007 07/12/2007 07/27/2007
0.09 04/10/2007 03/20/2007 04/12/2007 04/27/2007
0.09 01/10/2007 12/08/2006 01/12/2007 01/29/2007
0.09 10/10/2006 09/20/2006 10/12/2006 10/27/2006
0.08 07/10/2006 05/17/2006 07/12/2006 07/27/2006
0.08 04/10/2006 03/22/2006 04/12/2006 04/27/2006
0.08 01/10/2006 12/02/2005 01/12/2006 01/27/2006
0.08 10/07/2005 09/09/2005 10/12/2005 10/27/2005
0.06 07/08/2005 05/19/2005 07/12/2005 07/27/2005
0.06 04/08/2005 03/16/2005 04/12/2005 04/27/2005
0.06 01/10/2005 12/01/2004 01/12/2005 01/27/2005
0.06 10/07/2004 09/08/2004 10/12/2004 10/27/2004